Evaluation of the Frequency of Occurrence of Joint Pain With Bevacizumab in Patients With Ovarian, Colorectal or Bronchopulmonary Cancer

Self-administered questionnaire survey to determine the presence or absence of joint pain during bevacizumab treatment for lung, ovarian, colorectal cancers.
The principal end-point is the frequency of arthralgia after 6 months of treatment with Bevacizumab.

本研究采用自填式问卷调查法，以明确肺、卵巢及结直肠癌患者接受贝伐珠单抗（bevacizumab）治疗期间是否存在关节疼痛。本研究的主要终点为贝伐珠单抗治疗6个月后关节痛（arthralgia）的发生频率。